| Name | Title | Contact Details |
|---|
Portola Pharmaceuticals is dedicated to developing and commercializing therapies that transform patient lives and advance patient care by changing treatment paradigms in thrombosis and other hematologic diseases. Our two lead assets are Bevyxxa® (betrixaban), and andexanet alfa. In addition, cerdulatinib is our investigational Syk/JAK inhibitor to treat hematologic cancers. These compounds come from our own internal research efforts and represent important advances to address significant unmet needs. We are employing novel strategies that may increase the likelihood of clinical, regulatory and commercial success of our potentially lifesaving therapies.
Priority Life Care, a family-owned company, was built on the thought that every senior deserves quality care regardless of their economic background. With over a decade of experience, the family has been a pioneer in the industry giving a win-win solution for both seniors and coworkers (the #PLCfamily). Our focus on senior living includes independent living, assisted living, and memory care. The key to our approach is in our purpose of supporting independence. In addition to care, our residents are able to continue living out their lives with healthy choices tailored to their individual needs.
Washington Regional Transplant Consortium is a Annandale, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nutraceutical International Corporation (Nutraceutical) is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores
KPR is a Granada Hills, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.